Plan A™ Offers a New Option in Male Birth Control

ORIGINALLY POSTED ON Medical Device + Diagnostic Industry

Katie Hobbins | Aug 22, 2023

Recently, MD+DI sat down with L.R. Fox, founder and CEO of NEXT Life Sciences, to discuss Plan A, a non-hormonal, long lasting, and reversible male contraception option that uses Vasalgel as a medical device to block the flow of sperm within the vas deferens for up to 10 years to prevent pregnancy. Highlighting the burden of birth control usually placed on women, Fox noted that Plan A would give men an option other than condoms or a vasectomy to play an active role in birth control and family planning.

READ MORE ON Medical Device + Diagnostic Industry

Previous
Previous

Mission-Driven Entrepreneurship with Founder L.R. Fox

Next
Next

World’s Leading Vasectomists and Male Contraceptive Experts Join in Support of Plan A: Male Birth Control